Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

OncoTargets and Therapy Volume 14, 2021 - Issue

Submit an article Journal homepage

Open access

106

Views

CrossRef citations to date

Altmetric

Review

Progress in Treatment of Non-Small Cell Lung Cancer Harboring HER2 Aberrations

Jun NiDepartment of Pulmonary and Critical Care Medicine, Peking Union Medical Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, People’s Republic of China

Li ZhangDepartment of Pulmonary and Critical Care Medicine, Peking Union Medical Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, People’s Republic of ChinaCorrespondence[email protected]

Pages 4087-4098 | Published online: 06 Jul 2021

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (6)

Ola Abu Al Karsaneh, Arwa Al Anber, Mohammad ALQudah, Sahar Al-Mustafa, Hussien AlMa’aitah & Maher Sughayer. (2023) Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients. Diagnostic Pathology 18:1.
Crossref

Man Wang, Lijie Zhu, Xiaoxu Yang, Jiahui Li, Yu’e Liu & Ying Tang. (2023) Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer. Frontiers in Pharmacology 14.
Crossref

Ajay P. Jayan, K. R. Anandu, Krishnadas Madhu & V. N. Saiprabha. (2022) A pharmacological exploration of targeted drug therapy in non-small cell lung cancer. Medical Oncology 39:10.
Crossref

Yang Chen, Huan Wu, Annan Jiao, Jiabing Tong, Jie Zhu, Mei Zhang, Zegeng Li & Ping Li. (2022) Chinese Herbal Prescription QYSL Prevents Progression of Lung Cancer by Targeting Tumor Microenvironment. Oncologie 24:2, pages 295-307.
Crossref

Diego Kauffmann-Guerrero & Amanda Tufman. (2022) Rare driver alterations in nonsmall cell lung cancer: novel targeted drugs. Current Opinion in Oncology 34:1, pages 77-82.
Crossref

Ali Bashiri Dezfouli, Mina Yazdi, Alan Graham Pockley, Mohammad Khosravi, Sebastian Kobold, Ernst Wagner & Gabriele Multhoff. (2021) NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development. Cells 10:12, pages 3390.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references